Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.24B |
| 3 |
Chevron
CVX
|
+$472M |
| 4 |
Pfizer
PFE
|
+$372M |
| 5 |
Amazon
AMZN
|
+$369M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| 1 | Technology | 22.61% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZUO
2026
DELISTED
Zuora, Inc.
ZUO
| $9.94M | ﹤0.01% |
1,153,372
+4,432
| +0.4% | +$38.2K |
|
2027
Alignment Healthcare
ALHC
$3.18B
| $9.93M | ﹤0.01% |
839,695
+13,865
| +2% | +$164K |
|
2028
Astec Industries
ASTE
$1.06B
| $9.87M | ﹤0.01% |
308,881
-44,360
| -13% | -$1.42M |
|
2029
ProPetro Holding
PUMP
$484M
| $9.81M | ﹤0.01% |
1,281,081
-269,526
| -17% | -$2.06M |
|
2030
Core Laboratories
CLB
$581M
| $9.81M | ﹤0.01% |
529,522
-70,389
| -12% | -$1.3M |
|
2031
Unilever
UL
$154B
| $9.81M | ﹤0.01% |
151,027
+31,186
| +26% | +$2.03M |
|
2032
Spyre Therapeutics
SYRE
$945M
| $9.8M | ﹤0.01% |
333,275
+235,094
| +239% | +$6.91M |
|
2033
Capitol Federal Financial
CFFN
$839M
| $9.77M | ﹤0.01% |
1,673,095
-237,757
| -12% | -$1.39M |
|
2034
HSBC
HSBC
$238B
| $9.75M | ﹤0.01% |
215,748
+27,495
| +15% | +$1.24M |
|
2035
Soleno Therapeutics
SLNO
$2.85B
| $9.72M | ﹤0.01% |
192,597
+130,080
| +208% | +$6.57M |
|
2036
Protolabs
PRLB
$1.18B
| $9.72M | ﹤0.01% |
330,798
-17,972
| -5% | -$528K |
|
2037
Standard Motor Products
SMP
$889M
| $9.71M | ﹤0.01% |
292,512
-33,436
| -10% | -$1.11M |
|
2038
Sphere Entertainment
SPHR
$2.1B
| $9.71M | ﹤0.01% |
219,792
+2,187
| +1% | +$96.6K |
|
2039
Ocular Therapeutix
OCUL
$2.23B
| $9.66M | ﹤0.01% |
1,110,460
+660,080
| +147% | +$5.74M |
|
2040
DXP Enterprises
DXPE
$1.85B
| $9.66M | ﹤0.01% |
181,022
-29,281
| -14% | -$1.56M |
|
2041
Sturm, Ruger & Co
RGR
$600M
| $9.66M | ﹤0.01% |
231,686
-40,573
| -15% | -$1.69M |
|
2042
RPC Inc
RES
$986M
| $9.6M | ﹤0.01% |
1,509,478
+106,108
| +8% | +$675K |
|
2043
Heidrick & Struggles
HSII
$1.03B
| $9.6M | ﹤0.01% |
247,011
-26,801
| -10% | -$1.04M |
|
2044
Center Bancorp
CNOB
$1.26B
| $9.58M | ﹤0.01% |
382,524
-39,706
| -9% | -$995K |
|
2045
Jamf
JAMF
$1.41B
| $9.58M | ﹤0.01% |
552,266
+42,582
| +8% | +$739K |
|
2046
Trump Media & Technology Group
DJT
$4.75B
| $9.56M | ﹤0.01% |
595,159
+329,288
| +124% | +$5.29M |
|
2047
Community Health Systems
CYH
$412M
| $9.56M | ﹤0.01% |
1,574,190
-253,806
| -14% | -$1.54M |
|
2048
Tarsus Pharmaceuticals
TARS
$2.08B
| $9.54M | ﹤0.01% |
290,009
+28,130
| +11% | +$925K |
|
2049
BHP
BHP
$137B
| $9.51M | ﹤0.01% |
153,170
+22,677
| +17% | +$1.41M |
|
2050
TransAlta
TAC
$3.75B
| $9.49M | ﹤0.01% |
914,238
-45,222
| -5% | -$469K |
|